Profile
MBX Capital is a venture capital firm founded in 2015, based in Claymont, Delaware. The firm specializes in early-stage investments in healthcare, biotechnology, and "deep health" companies that integrate biology, chemistry, AI/ML, robotics, and clinical medicine. As of June 2024, MBX Capital manages over $100 million in assets and focuses on pre-seed, seed, and Series A funding rounds.
The firm targets startups that address public health challenges, including environmental health, healthcare infrastructure, and chronic diseases. MBX Capital typically invests between $100K and $3M, with initial checks ranging from $1 to $2.5 million for at least 5% ownership. They support founders through their Atom Network, which connects them with a wide range of scientific and industry experts. MBX Capital has made 37 investments across more than 30 companies, with a portfolio that includes life sciences, consumer products, and business services.
Industry
MBX Capital Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
MBX Capital III-A
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
Technology
Life Sciences
HealthTech
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$1 M
|
March 2025
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.